Diversification, expression, and gamma delta T cell recognition of evolutionarily distant members of the MIC family of major histocompatibility

complex class I-related molecules Alexander Steinle, Veronika Groh, and Thomas Spies PNAS 1998;95;12510-12515 doi:10.1073/pnas.95.21.12510 This information is current as of October 2006.
Online Information & Services References High-resolution figures, a citation map, links to PubMed and Google Scholar, etc., can be found at: www.pnas.org/cgi/content/full/95/21/12510 This article cites 31 articles, 13 of which you can access for free at: www.pnas.org/cgi/content/full/95/21/12510#BIBL This article has been cited by other articles: www.pnas.org/cgi/content/full/95/21/12510#otherarticles E-mail Alerts Rights & Permissions Reprints Receive free email alerts when new articles cite this article - sign up in the box at the top right corner of the article or click here. To reproduce this article in part (figures, tables) or in entirety, see: www.pnas.org/misc/rightperm.shtml To order reprints, see: www.pnas.org/misc/reprints.shtml

Notes:

Proc. Natl. Acad. Sci. USA Vol. 95, pp. 1251012515, October 1998 Immunology

Diversification, expression, and T cell recognition of evolutionarily distant members of the MIC family of major histocompatibility complex class I-related molecules
A LEXANDER STEINLE, VERONIKA GROH,
AND

THOMAS SPIES

Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109-1024

Edited by Sherman M. Weissman, Yale University School of Medicine, New Haven, CT, and approved August 4, 1998 (received for review April 27, 1998)

ABSTRACT Distant relatives of major histocompatibility complex (MHC) class I molecules, human MICA and MICB, function as stress-induced antigens that are broadly recogT cells. They may thus play a nized by intestinal epithelial central role in the immune surveillance of damaged, infected, or otherwise stressed intestinal epithelial cells. However, the generality of this system in evolution and the mode of recognition of MICA and MICB are undefined. Analysis of cDNA sequences from various primate species defined translation products that are homologous to MICA and MICB. All of the MIC polypeptides have common characteristics, although they are extraordinarily diverse. The most notable alterations are several deletions and frequent amino acid substitutions in the putative -helical regions of the 1 2 domains. However, the primate MIC molecules were expressed on the surfaces of normal and transfected cells. Moreover, despite their sharing of relatively few identical amino acids in potentially accessible regions of their 1 2 domains, they were recognized by diverse T cells that are restricted by human intestinal epithelial MICA and MICB. Thus, MIC molecules represent a family of MHC proteins that are structurally diverse yet appear to be T cell functionally conserved. The promiscuous mode of recognition of these antigens may be explained by their sharing of a single conserved interaction site. The extended family of major histocompatibility complex (MHC) class I-related proteins serves a variety of immunological functions, among which those of the polymorphic MHC class I molecules are paramount (1). These heterodimers of a membrane-anchored class I chain and soluble 2-microglobulin ( 2m) present intracellularly processed peptide antigens to T cell receptors (TCRs), thus cytotoxic T cells with facilitating the elimination of pathogen-infected cells (2). Class I chains have three extracellular domains, of which the membrane-distal 1 2 domains fold to bind peptide between two -helices on the platform of a -pleated sheet (3, 4). Both the -helices and bound peptide are involved in extensive contacts made by - and -chain variable regions of antigen-specific TCRs (5, 6). The membrane-proximal 3 domain includes contact residues for 2m and the main binding site for the T cell coreceptor CD8 (3). These structurefunction relationships, however, are greatly modified among molecules that are distantly related to MHC class I (7). Among these are the CD1 molecules, which present mycobacterial lipids and glycolipids T cells (8, 9). A more recent example is represented to some by the human MHC class I-related chains A and B (MICA and MICB), which function as stress antigens that are broadly T cells (10). recognized by intestinal intraepithelial
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. 1734 solely to indicate this fact.
1998 by The National Academy of Sciences 0027-8424 98 9512510-6$2.00 0 PNAS is available online at www.pnas.org.

Although MICA and MICB are encoded in the MHC, they are highly divergent from conventional MHC class I, with an average of only 27% amino acid sequence identity in the extracellular 1 2 3 domains (11). MICA and MICB themselves are closely related, sharing 84% identical amino acids (12). Both are highly glycosylated cell surface proteins that lack the binding site for CD8 (11, 13). As inferred from studies mostly of MICA, they are neither associated with 2m nor with peptides derived from class I antigen processing or other cellular sources (10, 13). The expression of MICA and MICB is regulated similar to heat shock protein 70 (hsp70), with both proteins being strongly induced on proliferating or heat shockstressed epithelial cells (10). By immunohistochemistry, in vivo expression of MICA has so far been found limited to intestinal epithelial cells (13). The structural and functional characteristics of MICA and MICB are matched by their specific recognition by intestinal epithelial T cells expressing the variable region V 1 (10). These are a majority of oligoclonal and mostly CD8 negative T cells in the intestinal mucosa that have been conceptualized to interact with self-antigen instead of foreign peptide or nonpeptide antigens (14, 15). Because stress-induced MICA and MICB are recognized by V1 T cells expressing variable TCRs, they may be at the center of an immune surveillance system that is dedicated to the detection of damaged, infected, or otherwise stressed intestinal epithelial cells (10). However, the broad recognition of MICA and MICB implies an unusual mode of interaction with the V 1 T cells, and the generality of this system is not decisively proven. Sequences homologous to the human genes for MICA and MICB occur in the genomes of diverse mammalian species but have not been characterized (11). We have studied the expression and structural and functional similarities of these sequences obtained as corresponding cDNAs from a number of evolutionarily distant primate species. Although all of the encoded MIC polypeptides share a distinctive array of characteristics, they are extraordinarily diverse, suggesting that unknown selective forces may have driven their rapid evolution or that a lack of functional constraints may have permitted genetic drift. Strikingly, however, all primate MIC molecules expressed on the surfaces of transfected cells were recognized by human V 1 T cells specific for MICA and MICB. These results support the model that MICA and MICB are the physiological antigens recognized by intestinal epithelial V 1 T cells and suggest the existence of a single conserved recognition site. MICA and MICB and their evolutionarily distant relatives represent components of a recently defined
This paper was submitted directly (Track II) to the Proceedings office. Abbreviations: MHC, major histocompatibility complex; MIC, MHC class I-related chain; 2m, 2-microglobulin; TCR, T cell receptor. Data deposition: The sequences reported in this paper have been deposited in the GenBank database (accession nos. AF055384 AF055390). To whom reprint requests should be addressed. e-mail: tspies@fred.fhcrc.org.

12510

Immunology: Steinle et al. branch of the innate immune system that is likely to be common to most, if not all, mammals.

Proc. Natl. Acad. Sci. USA 95 (1998)

12511

MATERIALS AND METHODS

Cell Lines, Transfections, and Antibodies. HCT116 is a human colon carcinoma cell line. The primate kidney epithelial cell lines FRhK-4, COS-1 and CV-1, OMK, and NZP-60 are derived from rhesus monkey (Macaca mulatta), African green monkey (Cercopithecus aethiops), owl monkey (Aotus trivirgatus), and silvery marmoset (Callithrix argentata), respectively. WES is a skin cell line from chimpanzee (Pan troglodytes). All cell lines were from the American Type Culture Collection (Manassas, VA) and were grown in DMEM supplemented with 10% fetal bovine serum, glutamine, and antibiotics. C1R cells were transfected with cDNAs in RSV.5neo and stable transfectants were selected with G418 (1.5 mg ml), as described (16). C1R-MICB transfectants have been described (10). The mAb 6G6 was generated by immunization of mice with mouse LTKMICA transfectants and recognizes an epitope on the 3 domain of MICA and MICB; this mAb is of the IgG1 isotype (V.G., unpublished data) (13). The polyclonal antiserum (provided by S. Bauer, Fred Hutchinson Cancer Research Center, Seattle) was raised in rabbits by immunization with soluble MICA protein lacking transmembrane and cytoplasmic tail sequences; the soluble protein was expressed in Drosophila Schneider cells and purified from culture supernatant as described (17). Surface expression of MIC molecules on cell lines and transfectants was detected by indirect immunofluorescence stainings using mAb 6G6 or the polyclonal antiserum, f luorochromeconjugated goat anti-mouse or anti-rabbit Ig, and a FACScan flow cytometer (Becton Dickinson). RNA Blot Hybridization, cDNA Cloning, and Sequence Analysis. For mRNA blot hybridization, total RNA isolated with STAT-60 reagent (Tel-Test, Friendswood, TX) was denatured and fractionated in a 1% agarose-formaldehyde gel (20 g RNA lane). After transfer onto nitrocellulose membrane, hybridization was carried out at 65C with MICA cDNA labeled with [32P]dCTP by random hexamer priming. Washings were in 1 SSC (0.15 M NaCl 0.015 M sodium citrate) 0.1% NaDodSO4, at 65C. Total cDNA was synthesized using oligo(dT) and avian myeloblastosis virus (AMV) reverse transcriptase (Promega). MIC cDNAs were amplified by PCR in 3540 cycles of 30 s at 94C, 20 s at 54C, and 90 s at 72C. Patr-MIC1, Mamu-MIC2, Ceae-MIC2, and Aotr-MIC1 cDNAs were obtained with primer sets EXP5 (5 -gcgacgtcgacGCCATGGGGCTGGGC-3 ) and EXP3 (5 -gtggatcCTAGGCGCCCTCAGTG-3 ) designed for the amplification of MICA cDNA (small letters denote adaptor sequences, including restriction sites for cloning) (11). Mamu-MIC1 and Ceae-MIC1 cDNAs were obtained with primers EXP5B and EXP3B, which are CGGGTCGTGCTA and GAGCCAG 3 -end extensions of

FIG. 1. Expression of MICA- and MICB-related mRNAs and proteins by nonhuman primate epithelial cell lines. (A) Hybridization of total RNA samples detected one or two MIC mRNAs in various cell lines derived from chimpanzee (WES), African green monkey (COS and CV-1), rhesus monkey (FRhK-4), owl monkey (OMK), and silvery marmoset (NZP-60). HCT116 is a human colon carcinoma cell line; the lower and upper bands correspond to MICA and MICB mRNA, respectively. Numbers on the right indicate sizes in kilobases. (B) Flow cytometry with mAb 6G6 detected MIC-related molecules on the surfaces of several primate cell lines (filled profiles). Open profiles are IgG1 isotype control stainings. Shaded profiles are stainings with mAb W6 32 (anti-MHC class I HLA-A, -B, and -C) (30).

EXP5 and EXP3, respectively. The Caar-MIC1 sequence was amplified by using EXP3 and a degenerate primer [5 -ccgtcgacGCTGAGCCCCA(C T)AG(C T)(C T)T(A C G T)CG-3 ] derived from the 5 end of the MICA 1 sequence (11). Amplicons were sequenced directly and after cloning using an automated sequencer (Applied Biosystems). Sequences were aligned with human MICB*01 (12) by using PILEUP and PRETTY of the Wisconsin Package version 9.1, Genetics Computer Group (GCG). The GenBank accession numbers of the Patr-MIC1, Ceae-MIC1, Ceae-MIC2, Mamu-MIC1, MamuMIC2, Aotr-MIC1, and Caar-MIC1 sequences, in this order, are AF055384AF055390. T cell T Cells and Cytotoxicity Assays. The human V 1 clones 1B-S1, 1B-S3, and 1B-S4 have been derived from an intestinal epithelial tumor. Their phenotypical and functional characteristics, specificity for MICA and MICB, and expressed TCR chain sequences have been described (10). The CT

Table 1. Primate species and cell lines referred to in this study, MIC gene designations, and numbers and sizes of mRNA transcripts Species Human Chimpanzee (Pan troglodytes) Rhesus monkey (Macacca mulatta) African green monkey (Cercopithecus aethiops) Owl monkey (Aotus trivirgatus) Silvery marmoset (Callithrix argentata) Family Hominidae Hominidae Cercopithecidae (OWM) Cercopithecidae (OWM) Cebidae (NWM) Callitrichidae (NWM) Cell lines HCT116 WES FRhK-4 COS-1 CV-1 OMK NZP-60 MIC genes MICA MICB Patr-MIC1 Mamu-MIC1 Mamu-MIC2 Ceae-MIC1 Ceae-MIC2 Aotr-MIC1 Caar-MIC1 mRNAs, kb 1.4 2.4 2.4 1.5, 2.3 2.3, 3.0 1.6 1.4

12512

Immunology: Steinle et al.

Proc. Natl. Acad. Sci. USA 95 (1998)

FIG. 2. Diversity of primate MIC molecules. Amino acid sequences deduced from cDNAs are compared with MICA*01 and MICB*01 (12, 23). The 1, 2, 3, and transmembrane (TM) and cytoplasmic tail (CYT) sequences are shown separately. Numbering refers to the MICB*01 sequence. Dashes and dots indicate identical residues or gaps and unaligned sequences, respectively. The positions of the highly conserved cysteines are shown in black. Shaded sequences are potential NXS T glycosylation sites. Asterisks below sequences identify amino acid residues that are conserved among all vertebrate MHC class I sequences and open triangles indicate the positions of the conserved Tyr-7 and Tyr-171 (4, 20). Bars below the 1 and 2 sequence alignments indicate tentative extensions of -helical sequences inferred from the previous comparison of MICA with HLA-A2 (11).

V 1 T cells isolated from another intestinal epithelial tumor have very similar characteristics (TCR , V 1 , TCR , CD4 , CD8 , integrin E 7 ) and are cytolytic against target cells expressing MICA or MICB. Their TCRs are composed of V 1.8 and a predominant V 1 (NDN) J 1 chain (V.G., unpublished data). The sodium [51Cr]chromate release assays were carried out as before, and specific lysis (in percent) was calculated by using the standard formula (10).

RESULTS AND DISCUSSION

Expression of MICA- and MICB-Related Sequences in Nonhuman Primate Cell Lines and Isolation of Corresponding cDNAs. In accord with the lack of expression of MICA and MICB in most human hemopoetic cell lines (11, 13), reverse transcriptionPCR (RT-PCR) yielded no homologous cDNA amplicons from various nonhuman primate B cell lines. Epithelial cell lines derived from skin or kidney were available from chimpanzee (Hominidae), African green monkey, and rhesus monkey (Cercopithecidae), owl monkey (Cebidae), and marmoset (Callitrichidae). The family Cercopithecidae represents the Old World monkeys (OWM), whereas Cebidae and Callitrichidae are the two extant families of New World monkeys (NWM), which separated from OWM about 57 million years ago (18). With all of the five epithelial cell lines, blot hybridization of total RNA samples detected one or two MICA- and MICB-related mRNA transcripts that ranged between 1.4 and 3.0 kb in length (Table 1; Fig. 1A). With the chimpanzee and OWM cell lines, substantial amounts of cell surface molecules were detected by flow cytometry with the mAb 6G6, which recognizes an epitope on the 3 domains of

human MICA and MICB (Fig. 1B) (V.G., unpublished data). Corresponding cDNAs were obtained from the five primate epithelial cell lines by RT-PCR by using specific oligonucleotide primer pairs and analyzed by sequencing of amplicons directly, and after cloning; because of primer selection, the marmoset sequence was incomplete at the 5 end (see Materials and Methods) (Fig. 2). The sequences were termed by an abbreviation of the species name (19), followed by MIC1 or MIC2, dependent on the number of gene products found (Table 1). We avoided the MICA and MICB terminology because of the probable recent derivation of these genes by duplication. Two MIC sequences, which by interspecies sequence similarity comparisons were nonallelic and corresponded to distinct genes, were obtained from the rhesus and African green monkey cell lines (Fig. 2). These results provided evidence for expression of MICA- and MICB-related mRNAs and proteins in species other than humans. Conserved Characteristics of MIC Polypeptides. All of the cDNA sequences have a single long ORF including the extracellular 1 2 3 domains and a transmembrane region distinctly homologous to human MICA and MICB. Two of the sequences (rhesus Mamu-MIC1 and marmoset Caar-MIC1) have premature stop codons after the transmembrane region and thus lack part or all of a cytoplasmic tail, which may not be essential for function (Fig. 2). Conserved MHC class I signature amino acid residues include the two pairs of cysteines in 2 3 involved in disulfide bonding and a small number of other positions that are common to all vertebrate MHC class I chains (Fig. 2) (11, 20). All of the MIC polypeptide sequences include Tyr-7 and Tyr-171, which interact with the amino terminus of bound peptide in MHC class I molecules (4). Both

Immunology: Steinle et al.

Proc. Natl. Acad. Sci. USA 95 (1998)

12513

FIG. 3. Recognition of diverse primate MIC molecules by human V 1 T cells specific for MICA and MICB. (AD) C1R cells transfected with the cDNAs for chimpanzee Patr-MIC1, rhesus monkey Mamu-MIC1, African green monkey Ceae-MIC2, or owl monkey Aotr-MIC1 expressed the encoded MIC proteins on the cell surface (filled profiles), as shown by immunofluorescence stainings and flow cytometry using mAb 6G6 (AC) and an anti-MICA polyclonal antiserum (D). Open profiles are control stainings of C1R cells mock-transfected with the neomycin selectable marker gene. (E and F) In standard chromium release assays, the various primate MIC transfectants, including C1R-MICB transfectants, were lysed by the human V 1 T cell clones 1B-S1 and 1B-S4 (10). C1R cells gave negative results. Similar data were obtained in at least one repeat experiment, as well as with C1R transfectants expressing Mamu-MIC2 or Ceae-MIC1. E:T, effector-to-target cell ratio.

of these residues are also present in the class I-related human Zn- 2-glycoprotein, which has no function as a peptide binding molecule (21, 22). The presence of these amino acids in MIC molecules may therefore reflect their evolutionary roots rather than an association with unidentified peptidic ligands, although the latter possibility is not entirely ruled out (10). Characteristic of human MICA and MICB is their extensive N-linked glycosylation at altogether 8 and 5 sites in their 1 2 3 domains, respectively (ref. 13; S. Bauer and T.S., unpublished data). Similar numbers of NXS T glycosylation acceptor sites are present in the nonhuman primate MIC polypeptides. Although there is some variability in the locations of these sites, none corresponds to the strictly conserved glycosylation site at position 86 in MHC class I chains (Fig. 2) (3). In most of the sequences, potentially glycosylated asparagines at positions 8 in 1 and 238 in 3 replace phenylalanine and aspartic acid at these aligned positions in MHC class I chains, respectively, which are conserved 2m contact residues (Fig. 2) (3). Thus, individual or cumulative steric effects of glycosylation of MIC molecules at single or multiple sites likely contribute to their lack of association with 2m (13). As with human MICA and MICB, the primate sequences lack most of the amino acid residues implicated in binding CD8 (11, 12). Thus, in agreement with the previous sequence, and biochemical and functional analyses of MICA and MICB, a distinctive pattern of family characteristics is shared by all MIC polypeptides. Extensive Diversity of MIC Polypeptides. The MIC polypeptides exhibit a high degree of variability, especially in the 1 2 superdomain, where several sequences (Ceae-MIC2, MamuMIC2, Aotr-MIC1, and Caar-MIC1) (Table 1) have 35 amino acid deletions at various locations within or adjacent to the putative -helices (Fig. 2). These microdeletions may alter the length of -helices and affect their positioning relative to the -sheet platform. No such alterations occur in the 3 domain sequences. As compared with human MICB, the 1 2 se-

quences display large numbers of amino acid substitutions, of which 80% are nonconservative (Fig. 2). Only 43% of the residues in these domains are identical in all of the primate MIC polypeptides including MICB. According to the previous alignment of MICA with HLA-A2 (11), a significantly lower fraction of 22% of the amino acids in the putative -helices are identical in all of the primate MIC sequences, whereas 58% of the remainder aligned 1 2 residues (excluding individual sequence gaps) are conserved. The 3 domain sequences exhibit significantly fewer amino acid substitutions, sharing 63% identical residues (Fig. 2). Unusual variability exists among the transmembrane region sequences, because of amino acid replacements, reading frame shifts, and alterations in numbers of GCT GTT nucleotide triplets (Fig. 2). Because these changes do not alter the overall hydrophobic character of the peptide sequences, and because similar changes occur among human MICA alleles without affecting surface expression (ref. 23; A.S., unpublished data), this variability may be of questionable functional significance. Recognition by Human V 1 T Cells of Diverse Primate MIC Molecules. The interaction of human intestinal epithelial V1 T cells with MICA and MICB involves an epitope or epitopes on their 1 2 domains alone, because anti- 1 2 but not anti- 3 domain-specific mAb inhibit recognition, and because expression of mouse H-2Db-MICA 1 2 hybrid molecules is sufficient to sensitize target cells to lysis (10). We explored structurefunction relationships by testing whether diverse primate MIC molecules were recognized by V 1 T cells specific for MICA and MICB. C1R cells were stably transfected with cDNA constructs directing the expression of all of the primate MIC polypeptides with the exception of Silvery marmoset Caar-MIC1 (Fig. 2). Surface expression of these proteins was confirmed by flow cytometry using mAb 6G6 or a rabbit antiserum raised against soluble MICA (Fig. 3 AD; data not shown). In chromium release assays with the C1R transfectants as labeled targets, the previously described

12514

Immunology: Steinle et al.

Proc. Natl. Acad. Sci. USA 95 (1998) T cells by providing indirect evidence that a epithelial V 1 similar system of immune surveillance may be conserved in other species. The existence of at least one functionally expressed MIC gene in all of the species examined affirms an important beneficial function of this family of genes and molecules. The results further argue against a recognition of these molecules in association with peptide or nonpeptide ligands, because similar binding and presentation of specific ligand by the diverse human and primate MIC molecules would seem implausible. This is in agreement with previous biochemical data and the proposed role of MICA and MICB as self antigens (10). The conservation of Tyr-7 and Tyr-171 may thus be viewed paradoxical. However, mutagenesis of both of these residues to phenylalanine in Patr-MIC1 had no effect on the expression and T cell recognition of the altered molecule (A.S. and V.G., unpublished data). The apparent conservation of a dominant V 1 T cell epitope on all of the MIC molecules tested indicates a mode of MHC ligandT cell interaction that is incompatible with the principles governing T cell recognition of MHC molecules (5, 6). However, there is some resemblance to the broad recognition of soluble phosphorylated nonpeptide antigens and their derivatives by human V 2 V 2 T cells (24, 25). Structural and functional evidence has indicated that TCRs may recognize antigens more akin to Igs than to TCRs (2628). According to this model, human V 1 T cells capable of recognizing MICA and MICB may have TCRs with conformationally similar antigen combining sites. This finding would fit with the recently found conservation of similar conformations by different TCRs expressed on dendritic epidermal cells from normal and TCR- chain mutant mice (29). The remarkable diversity displayed by the primate MIC molecules implies that unknown selective forces may have driven their rapid evolution or that a relative lack of functional constraints may have permitted genetic drift. In this regard, our functional results are not informative. This lack of knowledge highlights the importance of gaining precise understanding of the molecular interactions involved in T cell recognition of MIC antigens. Finally, these molecules could be adapted to a biological context including yet undefined cellular and immunological functions.
We thank anonymous reviewers for their helpful comments; S. Bauer for the rabbit antiserum; and D. Watkins for cell lines. A.S. was supported by a fellowship from the Deutsche Forschungsgemeinschaft. This work was supported by National Institutes of Health Grants RO1 AI30581 and PO1 CA18221. 1. 2. 3. 4. 5. 6. 7. 8. 9. Beckman, E. M. & Brenner, M. B. (1995) Immunol. Today 16, 349352. Germain, R. N. & Margulies, D. H. (1993) Annu. Rev. Immunol. 11, 403450. Bjorkman, P. J. & Parham, P. (1990) Annu. Rev. Biochem. 59, 253288. Madden, D. R. (1995) Annu. Rev. Immunol. 13, 587622. Garboczi, D. N., Ghosh, P., Utz, U., Fan, Q. R., Biddison, W. E. & Wiley, D. C. (1996) Nature (London) 384, 134141. Garcia, K. C., Degano, M., Pease, L. R., Huang, M., Peterson, P. A., Teyton, L. & Wilson, I. A. (1998) Science 279, 11661172. Wilson, I. A. & Bjorkman, P. J. (1998) Curr. Opin. Immunol. 10, 6773. Beckman, E. M., Porcelli, S. A., Morita, C. T., Behar, S. M., Furlong, S. T. & Brenner, M. B. (1994) Nature (London) 372, 691694. Sieling, P. A., Chatterjee, D., Porcelli, S. A., Prigozy, T. I., Mazzaccaro, R. J., Soriano, T., Bloom, B. R., Brenner, M. B., Kronenberg, M., Brennan, P. J & Modlin, R. L. (1995) Science 269, 227230. Groh, V., Steinle, A., Bauer, S. & Spies, T. (1998) Science 279, 17371740. Bahram, S., Bresnahan, M., Geraghty, D. E. & Spies, T. (1994) Proc. Natl. Acad. Sci. USA 91, 62596263.

FIG. 4. Hypothetical placement of amino acid residues that are conserved among human MICA*01 and MICB*01, chimpanzee PatrMIC1, rhesus monkey Mamu-MIC1 and -MIC2, African green monkey Ceae-MIC1 and -MIC2, and owl monkey Aotr-MIC1 on the ribbon diagram of HLA-A2 (adapted from ref. 31); conserved positions are shaded. These molecules were all recognized by the various V 1 T cell clones tested. This figure is intended to visualize sequence diversity associated with probable similar secondary structures and folds of MIC molecules, without implying any close similarity to HLA-A2. Numbers are for orientation in the sequence alignment (Fig. 2). Areas marked by broken lines indicate tentative locations of small deletions occurring in the Mamu-MIC2, Ceae-MIC2 and Aotr-MIC1 sequences.

V1 T cell clones 1B-S1, 1B-S3, and 1B-S4 recognized all of the six primate MIC molecules tested (Fig. 3 E and F; data not shown). The lytic activities were within the same range as those observed with C1R-MICB targets. Similar results T cell line were obtained with an intestinal epithelial V 1 (CT) derived from a different individual (data not shown). Thus, MIC molecules from species other than humans had the same function as MICA and MICB. Recognition of these molecules via TCR engagement is supported by anti-V 1 mAb-mediated inhibition of target cell lysis (10). The three T cell clones tested have diverse TCRs composed of V 1.3, -1.4, or -1.5, and V 1 J 1 chains with junctional regions differing in amino acid sequence and length (10). A fourth distinct V 1 J 1 chain paired with V 1.8 is predominantly expressed by the CT line (V.G., unpublished data). Hence, the recognition of the T various primate MIC molecules by the same human V 1 cells with variable TCRs indicated an unusual mode of interaction. The functionally tested primate MIC and human MICA and MICB polypeptides differ extensively in their 1 2 domain -helical regions, which, by extrapolation from T cell recognition of MHC class I and class II molecules, might be expected to present the main accessible surface that may TCRs (5, 6). Potentially common T cell interact with V 1 epitopes in these and adjacent regions may be further limited by the actual orientations of conserved amino acid side chains and the occurrences of three and or four amino acid deletions in three of the primate MIC molecules (Mamu-MIC2, CeaeMIC2, and Aotr-MIC1) (Figs. 2 and 4). Thus, unlike the TCRs with MHC class I peptide complexes, interactions of it seems certain that a recognition of the diverse MIC moleT cells with variable TCRs cannot cules by the same V 1 involve simultaneous engagements of different - and -chain variable regions. Our results may thus be best explained by the existence of a monomorphic epitope on MIC antigens that may be recognized by similar conformations shared among the different TCRs.

CONCLUSIONS
These results support the model that MICA and MICB represent the natural antigens recognized by human intestinal

10. 11.

Immunology: Steinle et al.

12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. Bahram, S. & Spies, T. (1996) Immunogenetics 43, 230233. Groh, V., Bahram, S., Bauer, S., Herman, A., Beauchamp, M. & Spies, T. (1996) Proc. Natl. Acad. Sci. USA 93, 1244512450. Chowers, Y., Holtmeier, W., Harwood, J., Morzycka-Wroblewska, E. & Kagnoff, M. F. (1994) J. Exp. Med. 180, 183190. Holtmeier, W., Witthoft, T., Hennemann, A., Winter, H. S. & Kagnoff, M. F. (1997) J. Immunol. 158, 56325641. Grandea, A. G., III, Androlewicz, M. J., Athwal, R. S., Geraghty, D. E. & Spies, T. (1995) Science 270, 105108. Bauer, S., Willie, S. T., Spies, T. & Strong, R. K. (1998) Acta Crystallogr. D 54, 451453. Takahata, N. & Satta, Y. (1997) Proc. Natl. Acad. Sci. USA 94, 48114815. Klein, J., Bontrop, R. E., Dawkins, R. L., Erlich, H. A., Gyllensten, U. B., Heise, E. R., Jones, P. P., Parham, P., Wakeland, E. K. & Watkins, D. I. (1990) Immunogenetics 31, 217219. Grossberger, D. & Parham, P. (1992) Immunogenetics 36, 166 174. Freije, J. P., Fueyo, A., Uria, J. & Lopez-Otin, C. (1991) FEBS Lett. 290, 247249. Sanchez, L. M., Lopez-Otin, C. & Bjorkman, P. J. (1997) Proc. Natl. Acad. Sci. USA 94, 46264630. 23. 24. 25. 26. 27. 28. 29. 30. 31.

Proc. Natl. Acad. Sci. USA 95 (1998)

12515

Fodil, N., Laloux, L., Wanner, V., Pellet, P., Hauptmann, G., Mizuki, N., Inoko, H., Spies, T., Theodorou, I. & Bahram, S. (1996) Immunogenetics 44, 351357. Constant, P., Davodeau, F., Peyrat, M. A., Poquet, Y., Puzo, G., Bonneville, M. & Fournie, J. J. (1994) Science 264, 267270. Tanaka, Y., Morita, C. T., Tanaka, Y., Nieves, E., Brenner, M. B. & Bloom, B. R. (1995) Nature (London) 375, 155158. Rock, E. P., Sibbald, P. R., Davis, M. M. & Chien, Y.-h. (1994) J. Exp. Med. 179, 323328. Schild, H., Mavaddat, N., Litzenberger, C., Ehrich, E. W., Davis, M. M., Bluestone, J. A., Matis, L., Draper, R. K. & Chien, Y. H. (1994) Cell 76, 2937. Li, H., Lebedeva, M. I., Llera, A. S., Fields, B. A., Brenner, M. B. & Mariuzza, R. A. (1998) Nature (London) 391, 502506. Mallick-Wood, C. A., Lewis, J. M., Richie, L. I., Owen, M. J., Tigelaar, R. E. & Hayday, A. C. (1998) Science 279, 17291733. Parham, P., Barnstable, C. J. & Bodmer, W. F. (1979) J. Immunol. 123, 342349. Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L. & Wiley, D. C. (1987) Nature (London) 329, 506512.